Tocilizumab in refractory anti-synthetase syndrome-associated interstitial lung disease:a phenotype-stratified cohort study.
- DOI
- 10.1186/s12931-026-03839-4
- Published
- 2026 Aug 3
- Container
- Respiratory research
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s12931-026-03839-4,
title = {Tocilizumab in refractory anti-synthetase syndrome-associated interstitial lung disease:a phenotype-stratified cohort study.},
author = {Yang H and Ge Y and Li S and Li W and He L and Chen F and Jiang W and Luo X and Shu X and Peng Q and Wang G and Lu X},
year = {2026},
journal = {Respiratory research},
doi = {10.1186/s12931-026-03839-4},
url = {https://doi.org/10.1186/s12931-026-03839-4}
}RIS
TY - JOUR TI - Tocilizumab in refractory anti-synthetase syndrome-associated interstitial lung disease:a phenotype-stratified cohort study. AU - Yang H AU - Ge Y AU - Li S AU - Li W AU - He L AU - Chen F AU - Jiang W AU - Luo X AU - Shu X AU - Peng Q AU - Wang G AU - Lu X PY - 2026 JO - Respiratory research DO - 10.1186/s12931-026-03839-4 UR - https://doi.org/10.1186/s12931-026-03839-4 ER -
APA
H, Y., Y, G., S, L., W, L., L, H., F, C., W, J., X, L., X, S., Q, P., G, W., & X, L. (2026). Tocilizumab in refractory anti-synthetase syndrome-associated interstitial lung disease:a phenotype-stratified cohort study.. Respiratory research. https://doi.org/10.1186/s12931-026-03839-4